127 related articles for article (PubMed ID: 12521463)
1. The management of women with apparent early ovarian cancer in the south-west region of England.
Olaitan A; Murdoch J; Weeks J; James J; Howe K
J Obstet Gynaecol; 2002 Jul; 22(4):394-8. PubMed ID: 12521463
[TBL] [Abstract][Full Text] [Related]
2. The surgical management of women with ovarian cancer in the south west of England.
Olaitan A; Weeks J; Mocroft A; Smith J; Howe K; Murdoch J
Br J Cancer; 2001 Dec; 85(12):1824-30. PubMed ID: 11747321
[TBL] [Abstract][Full Text] [Related]
3. Compliance to clinical guidelines for early-stage epithelial ovarian cancer in relation to patient outcome.
Sijmons EA; van Lankveld MA; Witteveen PO; Peeters PH; Koot VC; van Leeuwen JS
Eur J Obstet Gynecol Reprod Biol; 2007 Apr; 131(2):203-8. PubMed ID: 16707204
[TBL] [Abstract][Full Text] [Related]
4. How relevant are ACOG and SGO guidelines for referral of adnexal mass?
Dearking AC; Aletti GD; McGree ME; Weaver AL; Sommerfield MK; Cliby WA
Obstet Gynecol; 2007 Oct; 110(4):841-8. PubMed ID: 17906018
[TBL] [Abstract][Full Text] [Related]
5. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
[TBL] [Abstract][Full Text] [Related]
6. Preservation of ovarian function, reproductive ability and emotional attitudes in patients with malignant ovarian tumors.
Zanagnolo V; Sartori E; Trussardi E; Pasinetti B; Maggino T
Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):235-43. PubMed ID: 15921842
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study.
Suh-Burgmann E
Gynecol Oncol; 2006 Dec; 103(3):841-7. PubMed ID: 16793124
[TBL] [Abstract][Full Text] [Related]
8. Re-operation outcome in patients referred to a gynecologic oncology center with presumed ovarian cancer FIGO I-IIIA after sub-standard initial surgery.
Grabowski JP; Harter P; Buhrmann C; Lorenz D; Hils R; Kommoss S; Traut A; du Bois A
Surg Oncol; 2012 Mar; 21(1):31-5. PubMed ID: 20875732
[TBL] [Abstract][Full Text] [Related]
9. Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome.
Chan JK; Lin YG; Loizzi V; Ghobriel M; DiSaia PJ; Berman ML
J Reprod Med; 2003 Oct; 48(10):756-60. PubMed ID: 14619640
[TBL] [Abstract][Full Text] [Related]
10. Patterns of chemotherapy use for women with ovarian cancer: a population-based study.
Cress RD; O'Malley CD; Leiserowitz GS; Campleman SL
J Clin Oncol; 2003 Apr; 21(8):1530-5. PubMed ID: 12697877
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic fertility-sparing staging in unexpected early stage ovarian malignancies.
Muzii L; Palaia I; Sansone M; Calcagno M; Plotti F; Angioli R; Panici PB
Fertil Steril; 2009 Jun; 91(6):2632-7. PubMed ID: 18555237
[TBL] [Abstract][Full Text] [Related]
12. The accurate staging of ovarian cancer using 3T magnetic resonance imaging--a realistic option.
Booth SJ; Turnbull LW; Poole DR; Richmond I
BJOG; 2008 Jun; 115(7):894-901. PubMed ID: 18485169
[TBL] [Abstract][Full Text] [Related]
13. For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging?
Dizon DS; Restivo A; Lomme M; Charbonneau N; Brard L; Hughes T; Weitzen S; Legare R; Granai CO; Disilvestro P
Am J Clin Oncol; 2008 Feb; 31(1):39-42. PubMed ID: 18376226
[TBL] [Abstract][Full Text] [Related]
14. Fertility sparing therapy for ovarian cancer has inherent risks and benefits.
Douglas NC; Fan L; Pothuri B; Herzog TJ; Sauer MV
Arch Gynecol Obstet; 2005 Oct; 272(4):304-8. PubMed ID: 16001194
[TBL] [Abstract][Full Text] [Related]
15. Fertility-sparing surgery for ovarian low malignant potential tumors.
Rao GG; Skinner EN; Gehrig PA; Duska LR; Miller DS; Schorge JO
Gynecol Oncol; 2005 Aug; 98(2):263-6. PubMed ID: 15964063
[TBL] [Abstract][Full Text] [Related]
16. Incidence, pathology and outcome of gynaecological cancer in patients under the age of 21 years in South-west England 1995-2004: comparison of data from regional, national and international registries.
Hannemann M; Weeks J; Evans A; Pring A; Hirschowitz L
J Obstet Gynaecol; 2008 Oct; 28(7):722-7. PubMed ID: 19065369
[TBL] [Abstract][Full Text] [Related]
17. Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Société Francaise d'Oncologie Gynécologique).
Morice P; Leblanc E; Rey A; Baron M; Querleu D; Blanchot J; Duvillard P; Lhommé C; Castaigne D; Classe JM; Bonnier P;
Hum Reprod; 2005 May; 20(5):1379-85. PubMed ID: 15817592
[TBL] [Abstract][Full Text] [Related]
18. Surgical management of borderline ovarian tumors: The role of fertility-sparing surgery.
Park JY; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2009 Apr; 113(1):75-82. PubMed ID: 19171373
[TBL] [Abstract][Full Text] [Related]
19. Capturing tumour stage in a cancer information database.
Evans WK; Crook J; Read D; Morriss J; Logan DM
Cancer Prev Control; 1998 Dec; 2(6):304-9. PubMed ID: 10470461
[TBL] [Abstract][Full Text] [Related]
20. Outcome of ovarian cancer patients who underwent incomplete surgical staging.
Panprom P; Lertkhachonsuk R
J Med Assoc Thai; 2008 Sep; 91(9):1323-30. PubMed ID: 18843859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
